NASDAQ:INM - Nasdaq - CA4576377002 - Common Stock - Currency: USD
Intrigued by the market activity in the middle of the day on Monday? Uncover the key winners and losers of today's session in our insightful analysis.
The positive trial results propelled InMed into the top 25 trending stocks on Stocktwits, with a flood of bullish comments on the platform.
August 20, 2024 7:30 AM EDT | Source: InMed Pharmaceuticals High bioavailability of INM-901 oral formulation provides similar drug concentration levels in the brain as intraperitoneal (IP) injection Vancouver, British Columbia–(Newsfile Corp. – August 20, 2024) – InMed Pharmaceuticals Inc. (NASDAQ: INM) (“InMed” or the “Company”), a pharmaceutical company focused on developing a pipeline of […]
A good rating for growth in the Portfolio Grader doesn't tell the full picture. These are all growth stocks to avoid now.
Pre-market stock movers are worth checking out on Thursday morning as we dive into all of the hottest news affecting shares this morning!
InMed Pharmaceuticals just reported results for the third quarter of 2024.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips InMed Pharmaceuticals (NASDAQ:INM) just reported results for the third quarter ...
InMed Pharmaceuticals (INM) Friday announced the appointment of Netta Jagpal as Chief Financial Officer and Corporate Secretary, effective February 20. Jagpal j
Checking out the biggest pre-market stock movers for Tuesday is the perfect way to get ready for another busy day of trading!
InMed Pharmaceuticals files prospectus for resale of 12.57M shares by selling shareholders, not an offer to sell securities.